WHO said its decision was based on results from ongoing research in Ghana, Kenya and Malawi that has tracked more than 800,000 children since 2019.
Globally, the numbers of weekly COVID-19 cases and deaths continued to decline, WHO said.
Bharat Biotech has already completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age.
A WHO-led team of scientists that travelled to China in early 2021 to investigate the origins of the virus struggled to get a clear picture of what research China was conducting beforehand, faced constraints during its visit.
The latest guidance adds to previous recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical COVID-19.
Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.
The WHO is currently reviewing Covaxin data submitted by Bharat Biotech. According to WHO website, the date for a decision on the jab is yet to be confirmed.
The agencies said that, even before the Taliban's recent takeover of Afghanistan, the country required the world's third-largest humanitarian operation, with more than 18 million people needing help.
UNHCR, the UN refugee agency, has expressed concern about the prevailing humanitarian needs within Afghanistan and urged for continuous support to ensure necessary assistance in the country.
"We believe clearly that the data does not indicate that boosters are needed," Swaminathan said at a news conference in Geneva. She expressed more understanding for a recent U.S. decision to administer boosters to people with weaker immune systems.
According to the UN health agency, 70 WHO-supported medical facilities across Afghanistan treated nearly 14,000 conflict-related cases last month, which compares with 4,057 cases seen a year ago.
"So what we want to do for all parties, and everybody is calling for this, there's widespread agreement amongst all our member states, let's not politicise the process," the Xinhua news agency quoted him as saying.
Most of the new deaths were reported from the Americas and South-East Asia Regions, said the WHO.
Most of the 69,000 deaths were reported in the Americas and Southeast Asia. The UN health agency also noted that COVID-19 cases rose by 8 per cent worldwide and that there are now nearly 194 million infections.
The US and others say that China has not been transparent about what happened in the early days of the pandemic. China accuses critics of seeking to blame it for the pandemic and politicizing an issue that should be left to scientists.
WHO has acknowledged that it was premature to rule out a potential link between the pandemic and a leak of the coronavirus from a Chinese lab.
How infections are handled is what matters most, WHO director general Tedros Adhanom Ghebreyesus said in a speech to an International Olympic Committee meeting.
Tedros also drew the Emergency Committee on COVID-19's attention to the ongoing "shocking disparity" in the global distribution of vaccines, as well as unequal access to life-saving tools.
India has witnessed the greatest increase in the number of children not getting DPT 1 first last year as compared to 2019.
As of July 13, at least 111 countries, territories and areas have reported detection of the Delta variant, and this is expected to continue to increase, becoming the dominant variant globally in the coming months.
Top News
Latest News
